Previous Close | 24.26 |
1-Year Change | -7.58% |
6-Months Change | -11.01% |
3-Months Change | -21.62% |
Moving Avg (50d) | 24.354 |
Moving Avg (200d) | 28.208 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.566B |
Beta (3-Years) | 1.29 |
Revenue Growth (ttm) | 22.4% |
Net Profit Margin (ttm) | -15.57% |
Return On Assets (ttm) | -5.12% |
EPS (ttm) | -1 |
PE Ratio (ttm) | -24.26 |
Dividend Yield | % |
Asset Description: | OrthoPediatrics Corp. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-26 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
24.745 | 25.473 | 25.958 | 26.686 | 27.899 | 29.112 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.